MP78-17 A PHASE II STUDY TO EVALUATE OUTPATIENT, TRANSRECTALLY-DELIVERED, MRI-GUIDED LASER FOCAL THERAPY OF PROSTATE CANCER: 9 YEAR INTERIM RESULTS (NCT 02243033)

Abstract

INTRODUCTION AND OBJECTIVES:In the United States alone, new prostate cancer cases for 2018 were estimated at 164,690 and deaths at 29,430[1]. Focal therapies for prostate cancer are increasingly be...